Stockholders' Equity (Tables)
|
6 Months Ended |
Jun. 30, 2017 |
|---|
| Stockholders Equity Tables |
|
| Schedule of Aspire Option Agreement |
| Closing
price per share of common stock |
|
$ |
3.34 |
|
| Average
risk-free interest rate |
|
|
0.83 |
% |
| Average
expected life- years |
|
|
3.38 |
|
| Expected
volatility |
|
|
92.61 |
% |
| Expected
dividends |
|
|
0 |
% |
|
| Schedule of Future Amortization of Deferred Financing Costs |
| 2017 |
|
$ |
0.2 |
|
| 2018 |
|
$ |
0.5 |
|
| 2019 |
|
$ |
0.5 |
|
|
| Schedule of Warrants Outstanding |
| |
|
June
30, |
|
|
December
31, |
|
| |
|
2017 |
|
|
2016 |
|
| |
|
|
|
|
|
|
| Issued
to Investors on July 28, 2010, entitling the holders to purchase 207,000 common shares in the Company at an exercise price
of $45.00 per common share up to and including July 27, 2017. At June 30, 2017 and December 31, 2016, the fair value of these
warrants was not significant. |
|
|
207,000 |
|
|
|
207,000 |
|
| |
|
|
|
|
|
|
|
|
| Issued
to Investors on October 25, 2013, entitling the holders to purchase 250,000 common shares in the Company at an exercise price
of $6.25 per common share up to and including April 24, 2021. |
|
|
163,986 |
|
|
|
163,986 |
|
| |
|
|
|
|
|
|
|
|
| Issued
to Investors on November 17, 2014, entitling the holders to purchase 546,919 common shares in the Company at an exercise price
of 6.25 per common share up to and including May 16, 2022. |
|
|
546,919 |
|
|
|
546,919 |
|
| |
|
|
|
|
|
|
|
|
| Issued
to an Investor on June 28, 2016, entitling the holders to purchase 295,267 common shares in the Company at an exercise price
of $0.05 per common share (pre-funded) up to and including June 27, 2021. All of these warrants were exercised on a cashless
basis in July 2017. |
|
|
295,267 |
|
|
|
295,267 |
|
| |
|
|
|
|
|
|
|
|
| Issued
to an investor on August 10, 2016, entitling the holders to purchase 500,000 common shares in the Company at an exercise price
of price of $0.01 per share, up to and including December 31, 2019. |
|
|
500,000 |
|
|
|
500,000 |
|
| |
|
|
|
|
|
|
|
|
| |
|
|
1,713,172 |
|
|
|
1,713,172 |
|
|
| Schedule of Share-based Compensation, Stock Options, Activity |
| |
|
|
|
|
Weighted |
|
|
Weighted |
|
| |
|
|
|
|
Average |
|
|
Average |
|
| |
|
Options |
|
|
Exercise |
|
|
Grant Date |
|
| |
|
Outstanding |
|
|
Price |
|
|
Fair Value |
|
| Beginning of the period |
|
|
2,172,581 |
|
|
$ |
6.70 |
|
|
$ |
4.83 |
|
| Granted |
|
|
---- |
|
|
|
---- |
|
|
|
---- |
|
| Exercised |
|
|
---- |
|
|
|
---- |
|
|
|
---- |
|
| Forfeited |
|
|
---- |
|
|
|
---- |
|
|
|
---- |
|
| Expired |
|
|
(17,001 |
) |
|
$ |
37.74 |
|
|
$ |
33.78 |
|
| End of the period |
|
|
2,155,580 |
|
|
$ |
6.45 |
|
|
$ |
4.61 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Options exercisable |
|
|
1,768,746 |
|
|
$ |
6.81 |
|
|
$ |
4.92 |
|
|
| Schedule of Non-Vested Shares, Activity |
| |
|
|
|
|
Weighted- |
|
|
|
|
| |
|
|
|
|
Average Fair |
|
|
Weighted |
|
| |
|
|
|
|
Value |
|
|
Average |
|
| |
|
Shares |
|
|
Grant Date |
|
|
Exercise Price |
|
| Non-vested Shares |
|
|
|
|
|
|
|
|
|
| Non-vested - December 31, 2015 |
|
|
359,001 |
|
|
$ |
4.55 |
|
|
$ |
6.70 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Granted |
|
|
1,210,467 |
|
|
$ |
1.71 |
|
|
$ |
3.02 |
|
| Vested |
|
|
(1,118,992 |
) |
|
$ |
1.81 |
|
|
$ |
3.19 |
|
| Forfeited |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Non-vested - December 31, 2016 |
|
|
450,476 |
|
|
$ |
3.60 |
|
|
$ |
5.40 |
|
| Granted |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Vested |
|
|
(63,642 |
) |
|
$ |
6.09 |
|
|
$ |
9.03 |
|
| Forfeited |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Non-vested - June 30, 2017 |
|
|
386,834 |
|
|
$ |
3.22 |
|
|
$ |
4.81 |
|
|
| Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions |
| |
|
Year ended |
|
| |
|
December 31, |
|
| |
|
2016 |
|
| |
|
|
|
| Average risk-free interest rate |
|
|
1.57 |
% |
| Average expected life- years |
|
|
5.05 |
|
| Expected volatility |
|
|
87.74 |
% |
| Expected dividends |
|
|
0.0 |
|
|